20 – 21 September 2016
Marina Bay Sands, Singapore, Singapore

Jessica Thongcharen

Associate Director, Global Pharmacovigilance Operations,
Takeda Global Research & Development Center Asia Private Limited


15:45 Exploring Long-Term Strategies in Developing Core PV Processes: Outsourcing vs. Capacity Building


Discussing Asia’s strategic shift from outsourcing to innovation in research and development
Discovering opportunities and overcoming obstacles in building core PV processes in various parts of Asia.
When is it more justifiable to internalize PV functions?
Ensuring smooth transitions: how and when should one re-integrate outsourced functions into the company?


16:15 Mergers and Acquisition of PV Functions: How Do You Ensure Compliance is not Compromised?

Merger and acquisitions are increasingly on the rise in the pharmaceutical and bio-technology industry. Done out of financial or business reasons, PV is often considered as afterthought and may be addressed late in negotiations on post-conclusions, at the risk of compliance or safety:
How do you overcome operational challenges and manage the switch in ownership?
Ensuring safety systems continue uninterrupted and that PV functions are carried out in a timely manner
The role of the QPPV in ensuring a clear transition of responsibilities and the maintenance of activities
How is compliance assured across multiple databases?
Determining that all safety exchange agreements in place and valid



Check out the incredible speaker line-up to see who will be joining Jessica.

Download The Latest Agenda